Subscribe
Blog Editors
- Editor
- Editor
- Editor
- Editor
- Editor
- Editor
- Editor
- Editor
- Editor
- Editor
Topics
Archives
Posts from November 2020.
If an offer to a health care provider to speak at or attend a pharmaceutical or medical device company’s event seems too good to be true – it probably is, and it could lead to civil, criminal and federal administrative penalties.
On November 10, 2020, the U.S. Supreme Court held oral arguments in California, et. al. v. Texas, et. al., the most recent challenge to the Patient Protection and Affordable Care Act (ACA).